Aldeyra Therapeutics ALDX
NASDAQ ALDX
$1.23 -0.09 (-6.82%)
At close: Sep 30, 2026 · 4:00 PM EDT

Aldeyra Therapeutics (ALDX) Acquisitions (2019)

Updated

Aldeyra Therapeutics (ALDX) recorded Acquisitions of -$22,626 in Q4 2019.

Analysis

Aldeyra Therapeutics (ALDX) Acquisitions (2019) Analysis & Trends

For FY2019, Aldeyra Therapeutics reported Acquisitions of $609,464.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Acquisitions (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -17.24 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -23.00 Mn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 11.21 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 Aldeyra Therapeutics 74.19 Mn 74.19 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2019 -22,626.00
Sep 30, 2019 69,728.00
Mar 31, 2019 562,362.00
API Access

Aldeyra Therapeutics Acquisitions API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=acquisitions&ticker=ALDX&period=max&api_key=YOUR_API_KEY